Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs Y Schilt, T Berman, X Wei, Y Barenholz, U Raviv Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (1), 108-119, 2016 | 94 | 2016 |
Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules H Lei, Y Xu, J Chen, X Wei, DMK Lam Virology 407 (2), 319-324, 2010 | 74 | 2010 |
Insights into composition/structure/function relationships of Doxil® gained from “high-sensitivity” differential scanning calorimetry X Wei, R Cohen, Y Barenholz European Journal of Pharmaceutics and Biopharmaceutics 104, 260-270, 2016 | 67 | 2016 |
Evaluation of oral immunization with recombinant avian influenza virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin … H Lei, Z Sheng, Q Ding, J Chen, X Wei, DMK Lam, Y Xu Clinical and Vaccine Immunology 18 (7), 1046-1051, 2011 | 66 | 2011 |
Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in doxil properties and performance X Wei, D Shamrakov, S Nudelman, S Peretz-Damari, E Nativ-Roth, ... ACS omega 3 (3), 2508-2517, 2018 | 51 | 2018 |
Solubilization and delivery of Ursolic-acid for modulating tumor microenvironment and regulatory T cell activities in cancer immunotherapy N Zhang, S Liu, S Shi, Y Chen, F Xu, X Wei, Y Xu Journal of controlled release 320, 168-178, 2020 | 49 | 2020 |
Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties J Peng, Y Zhao, J Mai, WK Pang, X Wei, P Zhang, Y Xu Journal of general virology 86 (12), 3227-3234, 2005 | 46 | 2005 |
Multivesicular liposome formulations for the sustained delivery of interferon α-2b J Qiu, X Wei, F Geng, R Liu, J Zhang, Y Xu Acta Pharmacologica Sinica 26 (11), 1395-1401, 2005 | 45 | 2005 |
RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses Q Ding, J Chen, X Wei, W Sun, J Mai, Y Yang, Y Xu Pharmaceutical research 30, 60-69, 2013 | 44 | 2013 |
Synthesis and characterization of iron oxide/polymer composite nanoparticles with pendent functional groups S Liu, X Wei, M Chu, J Peng, Y Xu Colloids and Surfaces B: Biointerfaces 51 (2), 101-106, 2006 | 42 | 2006 |
Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA M Rui, H Tang, Y Li, X Wei, Y Xu Pharmaceutical research 30, 1203-1214, 2013 | 39 | 2013 |
Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver M Rui, W Guo, Q Ding, X Wei, J Xu, Y Xu International Journal of Nanomedicine, 3751-3768, 2012 | 27 | 2012 |
Characterization of pegylated liposomal mitomycin C lipid-based prodrug (Promitil) by high sensitivity differential scanning calorimetry and cryogenic transmission electron … X Wei, Y Patil, P Ohana, Y Amitay, H Shmeeda, A Gabizon, Y Barenholz Molecular pharmaceutics 14 (12), 4339-4345, 2017 | 26 | 2017 |
The delivery of a Wnt pathway inhibitor toward CSCs requires stable liposome encapsulation and delayed drug release in tumor tissues C Li, Y Liang, J Cao, N Zhang, X Wei, M Tu, F Xu, Y Xu Molecular Therapy 27 (9), 1558-1567, 2019 | 20 | 2019 |
Selective Targeting and Eradication of LGR5+ Cancer Stem Cells Using RSPO-Conjugated Doxorubicin Liposomes J Cao, C Li, X Wei, M Tu, Y Zhang, F Xu, Y Xu Molecular cancer therapeutics 17 (7), 1475-1485, 2018 | 18 | 2018 |
Stable loading and delivery of melittin with lipid-coated polymeric nanoparticles for effective tumor therapy with negligible systemic toxicity R Ye, Y Zheng, Y Chen, X Wei, S Shi, Y Chen, W Zhu, A Wang, L Yang, ... ACS Applied Materials & Interfaces 13 (47), 55902-55912, 2021 | 15 | 2021 |
Nano composite emulsion for sustained drug release and improved bioavailability W Sun, X Ma, X Wei, Y Xu Pharmaceutical research 31, 2774-2783, 2014 | 15 | 2014 |
Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs Y Schilt, T Berman, X Wei, E Nativ-Roth, Y Barenholz, U Raviv Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (5), 129849, 2021 | 14 | 2021 |
Liposomal contrast agent for CT imaging of the liver X Wei, F Geng, D He, J Qiu, Y Xu 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, 5702-5705, 2006 | 14 | 2006 |
Intra-articular treatment of temporomandibular joint osteoarthritis by injecting actively-loaded meloxicam liposomes with dual-functions of anti-inflammation and lubrication Y Zhong, Y Zhou, R Ding, L Zou, H Zhang, X Wei, D He Materials Today Bio 19, 100573, 2023 | 10 | 2023 |